The only randomized trial of cannabis for sickle cell disease pain found that vaporized cannabis did not reduce pain significantly more than placebo, though it did ease how much pain interfered with mood. Mouse studies of CBD are encouraging and a placebo-controlled CBD trial is now recruiting, but for now cannabis is not a proven treatment for sickle cell pain.
Sickle cell disease (SCD) is an inherited blood disorder in which red blood cells stiffen into a crescent shape, block small blood vessels and cause sudden, severe pain crises along with chronic daily pain. Many adults with SCD rely on opioids for long periods, so interest in cannabis as an alternative or add-on is strong, and surveys show many patients already use it. This page summarizes what the research shows as of 2026. For more health topics, see our cannabis research hub.
Evidence at a Glance: Cannabis and Sickle Cell Disease
| Claim | Evidence level | Source |
|---|---|---|
| Vaporized THC/CBD cannabis reduces chronic SCD pain more than placebo | Not shown (one small pilot RCT) | Abrams et al., JAMA Network Open, 2020 |
| Cannabis reduces pain interference with mood in SCD | Limited (secondary outcome, same trial) | Abrams et al., 2020 |
| Daily cannabis users with SCD have fewer hospital admissions | Limited (observational association) | Curtis et al., 2020 |
| Marijuana improves pain in SCD overall | Mixed to unsupported | Paulsingh et al., systematic review, 2022 |
| CBD reduces pain sensitivity in sickle cell mice | Preclinical only | Cherukury et al., Blood, 2023 |
| Cannabis or cannabinoids reduce chronic pain in adults (all causes) | Substantial | National Academies, 2017 |
Who Has Sickle Cell Disease
The CDC estimates SCD affects about 100,000 people in the United States, though the exact number is unknown. More than 90% are Black or African American, and an estimated 3% to 9% are Hispanic or Latino. SCD occurs in about 1 in every 365 Black or African American births. Pain is the defining symptom, and it is the main reason people with SCD go to the emergency room or hospital.
The Key Trial: Vaporized Cannabis vs Placebo
In 2020, researchers led by Dr. Donald Abrams at the University of California, San Francisco, published the first randomized clinical trial of cannabis in SCD in JAMA Network Open. Adults with chronic SCD pain stayed in a clinical research unit for two separate five-day periods. In one period they inhaled vaporized cannabis containing about 4.4% THC and 4.9% CBD three times a day; in the other they inhaled placebo cannabis. Twenty-three people completed both arms.
The results:
- Pain scores were lower with cannabis on every day, with the largest gap on day 3, but none of the differences was statistically significant.
- Pain interference with walking, sleep, general activity and enjoyment did not differ significantly.
- Pain interference with mood did fall significantly with cannabis.
- Side effects were similar in both periods, and opioid use did not change.
The trial was a small pilot, short, and run in a hospital, so it could easily miss a modest benefit. But it also means anyone claiming cannabis is proven to relieve sickle cell pain is overstating the data. The researchers called for larger studies.
What Observational Studies Show
A 2020 cross-sectional study by Curtis and colleagues compared adults with SCD who used cannabis daily with others matched for age, sex, disease type, hydroxyurea use and pain impact. The daily users actually reported more severe pain crises, yet had about 1.8 fewer hospital admissions and 1.2 fewer emergency room visits per year, with similar amounts of opioids dispensed. That is an interesting signal, but the design cannot show cause and effect. The authors themselves said randomized trials are needed.
A 2022 systematic review in Cureus pulled together seven studies of different designs and concluded that marijuana use in SCD either was linked to worse pain crises or offered little to no help compared with opioids or hydroxyurea. The evidence base was small and mostly observational, so this is not the final word either. The fair summary is that the data are mixed and thin.
CBD and Sickle Cell: Promising in Mice, Now in Human Trials
Much of the scientific interest now centers on CBD. A 2023 study in Blood from the same research network found that CBD reduced pain sensitivity in a mouse model of sickle cell disease. Animal results often fail to translate to people, so this is a reason to test CBD properly, not a reason to self-treat.
That testing is under way. A Phase 1/2 trial at the Icahn School of Medicine at Mount Sinai, SPICe (NCT06930703), is randomizing an estimated 52 adults to twice-daily CBD at 200, 400 or 600 mg, or placebo, for four weeks, to study pain and inflammation. It began in April 2025 and was listed as recruiting at the time of writing. Note those doses are far higher than most store-bought CBD products, and high-dose CBD can raise liver enzymes. Our guide to what CBD can and cannot do covers the wider evidence.
Standard Sickle Cell Care Comes First
SCD treatment has improved. The CDC notes hydroxyurea is recommended for children with sickle cell anemia from 9 months of age and can reduce pain crises and acute chest syndrome and improve survival. In December 2023 the FDA approved the first gene therapies for SCD in patients 12 and older. Cannabis, if it has a role, would be an add-on for symptoms, not a substitute for disease-modifying care from a hematologist.
Risks and Side Effects
- Lung health. Lung complications are a serious concern in SCD. The National Academies found substantial evidence that long-term cannabis smoking worsens respiratory symptoms and bronchitis episodes. The SCD trial used a vaporizer, not smoking. See our guide to the healthiest ways to use cannabis.
- Impairment and mental health. THC affects judgment and coordination, and frequent use is linked to a higher risk of psychosis and of developing problem use, according to the National Academies.
- Interactions with opioids and other drugs. Combining THC with opioids can add to sedation. CBD can change how the liver processes other medicines.
- Pregnancy. Maternal cannabis smoking is linked to lower birth weight, a finding the National Academies rated substantial.
- Delayed care. A pain crisis with fever, chest pain, trouble breathing or stroke symptoms is a medical emergency. Do not treat it at home with cannabis.
Talk to Your Doctor
Tell your hematologist if you use or plan to use cannabis, including CBD. That information affects how they plan pain management and read your lab results. Ask whether a clinical trial such as SPICe is open near you; joining a trial is the safest way to try CBD at research doses. If you live in Washington or Oregon and choose to use cannabis, buy from licensed, tested sources through our Washington dispensary directory, and know the rules in our Washington marijuana laws guide.
Sickle Cell Disease and Cannabis FAQ
Does marijuana help sickle cell pain?
It has not been proven to. In the only randomized trial, vaporized cannabis lowered pain scores somewhat, but not significantly more than placebo. It did reduce how much pain affected mood.
Is CBD good for sickle cell disease?
CBD reduced pain sensitivity in sickle cell mice, and a placebo-controlled trial in adults began in 2025. There are no completed human trials, so its benefit in people is unknown.
Can cannabis replace opioids for sickle cell pain crises?
No evidence supports that. In the 2020 trial, opioid use was similar with cannabis and placebo. Severe crises need medical care.
Why do some people with sickle cell use cannabis?
Many report it helps with pain, sleep, mood and appetite. One observational study found daily users had fewer hospital admissions, but that kind of study cannot prove cannabis was the reason.
Is it safe to smoke cannabis with sickle cell disease?
Smoking anything is a poor choice when lung complications are a major risk of the disease. Long-term cannabis smoking is linked to worse respiratory symptoms. Discuss any use with your hematologist.
For adults 21+ in legal states. General information, not medical advice. Talk to a doctor before using cannabis for a health condition.
